Alpha,beta-unsaturated sulfones for treating proliferative disorders

Details for Australian Patent Application No. 2001251614 (hide)

Owner Temple University - of the Commonwealth System of Higher Education

Inventors Reddy, E. Premkumar; Reddy, M. V. Ramana

Agent Mallesons

Pub. Number AU-B-2001251614

PCT Pub. Number WO01/78733

Priority 60197368 14.04.00 US

Filing date 13 April 2001

Wipo publication date 30 October 2001

Acceptance publication date 5 May 2005

International Classifications

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07D 211/70 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 241/04 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 031/275 - Nitriles

A61K 031/385 - having two or more sulfur atoms in the same ring

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/435 - having six-membered rings with one nitrogen as the only ring hetero atom

C07D 307/02 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 207/08 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

5 May 2005 Application Accepted

  Published as AU-B-2001251614

1 September 2005 Standard Patent Sealed

20 October 2005 Licence Registered

  Temple University - of the Commonwealth System of Higher Education ( Onconova Therapeutics, Inc. )

22 February 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 05 Dec 2006. Address for service in Australia - Mallesons Stephen Jaques Level 50 Bourke Place 600 Bourke Street MELBOURNE VIC 3000

12 July 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 05 Dec 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001251615-Substituted styryl benzylsulfones for treating proliferative disorders

2001251613